HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The therapeutic efficacy of ribamidil and virazole in experimental Lassa fever in monkeys].

Abstract
The therapeutic efficacy of ribamydil and virasol was evaluated in experimental Lassa fever in monkeys which received these drugs at various intervals after the onset of the clinical illness. Ribamydil or virasol administered in the first day of fever protected from death 60% to 66% of the infected animals, but when the drugs were given 2 days after the onset of fever the number of survivors declined to 0.20%. When the treatment was started 4 days after the onset of fever none of the drugs prevented deaths of Lassa virus-infected baboons.
AuthorsV I Dvoretskaia, G V Bogatikov, V A Pshenichnov, A A Evseev
JournalVoprosy virusologii (Vopr Virusol) 1991 Jan-Feb Vol. 36 Issue 1 Pg. 55-7 ISSN: 0507-4088 [Print] Russia (Federation)
Vernacular TitleTerapevticheskaia éffektivnost' ribamidila i virazola pri éksperimental'noĭ likhoradke Lassa u obez'ian.
PMID1858356 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Ribavirin
Topics
  • Animals
  • Body Temperature (drug effects)
  • Drug Evaluation, Preclinical
  • Injections, Intramuscular
  • Lassa Fever (drug therapy, microbiology, mortality)
  • Papio
  • Rectum
  • Ribavirin (therapeutic use)
  • Time Factors
  • Viremia (drug therapy, microbiology, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: